Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Organoid-Based Precision Medicine in Colorectal Cancer—Are We There Yet?

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. McMillin DW, Negri JM, Mitsiades CS. The role of tumour-stromal interactions in modifying drug response: challenges and opportunities. Nat Rev Drug Discov. 2013;12(3):217–28.

    Article  CAS  Google Scholar 

  2. Narasimhan V, Wright JA, Churchill M, et al. Medium-throughput drug screening of patient-derived organoids from colorectal peritoneal metastases to direct personalized therapy. Clin Cancer Res. 2020;26(14):3662–70.

    Article  CAS  Google Scholar 

  3. Flood M, Narasimhan V, Wilson K et al. Organoids as a robust preclinical model for precision medicine in colorectal cancer: a systematic review. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-10829-x.

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia

    Michael Flood MRCS, Robert Ramsay PhD & Alexander Heriot MD, MBA, FRACS

  2. Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia

    Michael Flood MRCS, Robert Ramsay PhD & Alexander Heriot MD, MBA, FRACS

Authors
  1. Michael Flood MRCS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert Ramsay PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alexander Heriot MD, MBA, FRACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Flood MRCS.

Ethics declarations

Disclosure

The Authors have no conflicts of interest. The National Health and Medical Research Council, Australia provided partial grant support for this study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Flood, M., Ramsay, R. & Heriot, A. ASO Author Reflections: Organoid-Based Precision Medicine in Colorectal Cancer—Are We There Yet?. Ann Surg Oncol 29, 60–61 (2022). https://doi.org/10.1245/s10434-021-10831-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-021-10831-3

Search

Navigation